Latest Scidev (ASX:SDV) News

SciDev Ltd has completed a strategic review addressing past underperformance and is refocusing on an integrated water solutions platform targeting core markets. The company confirmed FY26 guidance with revenue of $82 to $87 million and underlying EBITDA of approximately $4 million, while maintaining a sound balance sheet.

SciDev Ltd has announced an immediate CEO transition with CFO Todd Scott stepping up to lead, as outgoing CEO Seán Halpin moves to an advisory role. The company also names John Gardiner as interim CFO while seeking a permanent replacement.

SciDev Ltd trims FY26 revenue guidance to $82-$87 million from $100-$110 million due to intensified competition in Energy Services and weather-related delays at Rum Jungle, while maintaining positive EBITDA and a confident FY27 outlook.

SciDev Limited posted a $2.14 million loss for the half-year ending December 2025, impacted by restructuring costs and a failed acquisition. Despite a 4% revenue dip, the company secured a major $19.5 million contract and maintains a strong balance sheet.

SciDev Limited has secured a $19.5 million contract to design and build a groundwater treatment plant for the Rum Jungle Rehabilitation Project, tackling contamination from historic uranium mining near Darwin.

SciDev Limited reported a 5% revenue decline in FY25 but secured major contracts and reaffirmed strong growth guidance for FY26. Key proprietary technologies like CatChek™ and PFAS treatment are driving expansion.

SciDev Limited has confirmed winning $21.5 million in new and renewed contracts spanning key industrial sectors, reinforcing its position in specialty water treatment solutions.

SciDev Limited has secured $21.5 million in new contracts and renewals across oil & gas, mining, and PFAS remediation sectors, boosting its FY26 revenue guidance to $120-$140 million.

SciDev Limited reported a robust Q3 FY25 with revenue rising 10% and EBITDA tripling, driven by strategic US market expansion and a landmark PFAS remediation contract despite ongoing market challenges.

SciDev Ltd reports a seasonal revenue dip in Q2 FY25 due to US Oil & Gas sector uncertainty but marks a strategic milestone by securing its first PFAS treatment contracts in Europe.